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Introduction {#sec005}
============

Arthropod borne viruses (arboviruses) present a significant risk to public health globally. In recent decades, rapid urbanization and population growth have assisted the expansion of several viruses from having localised, rural, transmission cycles to being worldwide and urban problems \[[@pone.0229314.ref001]\]. Epidemiological cycles of many arboviruses, such as Ross River (RRV) and West Nile (WNV) incorporate complex transmission networks involving multiple vertebrate hosts and many vectors. Humans are not necessarily key components of these transmission networks, but increasing human travel, trade and deforestation bring humans into contact with sylvatic/enzootic cycles. This can stimulate arbovirus emergence, re-emergence and spillover into human populations \[[@pone.0229314.ref002]--[@pone.0229314.ref004]\].

A comprehensive knowledge of the transmission pathways of arboviruses is needed to effectively manage and respond to their emergence. Surveillance systems are needed to identify which mosquito species are responsible for transmission and which animals are acting as amplifying or reservoir hosts. However, the identification of amplifying hosts and transmission pathways remains extremely challenging.

More than 75 arboviruses have been identified in Australia and a small number are associated with human infection \[[@pone.0229314.ref005]\]. Of these, RRV \[[@pone.0229314.ref006]\], Barmah Forest virus \[[@pone.0229314.ref007]\], WNV strain Kunjin \[[@pone.0229314.ref008]\], and the potentially fatal Murray Valley encephalitis virus \[[@pone.0229314.ref009]\] are of the greatest public health concern. RRV is the most commonly notified arboviral disease but multiple vectors and many potential vertebrate hosts make this a complex zoonosis. There is little empirical evidence regarding its key transmission cycles or the factors that encourage their spillover to the human population \[[@pone.0229314.ref010], [@pone.0229314.ref011]\].

One means of identifying likely vertebrate disease reservoirs is to demonstrate their historical exposure to disease by searching for virus-specific antibodies in animal sera or tissues. Development of antibody is the major immune response to infection with parasites and pathogens including arboviruses \[[@pone.0229314.ref012], [@pone.0229314.ref013]\]. While such serological evidence of infection does not prove that an animal is an amplifying host or key reservoir, it does allow the generation of hypotheses about probable pathways and is especially useful when combined with information on mosquito species and their host preference. Serological surveys of blood meals are likely to be more fruitful than the direct identification of viruses because vertebrates are only viraemic for a few days, only a small proportion of mosquitoes are virus positive and there is a diminishingly small probability that a captured mosquito will be carrying a virus positive mosquito blood meal. A tremendous sampling effort is therefore required to incriminate reservoir and vector pathways by virus isolation alone.

The potential for screening mosquito blood meals for antibodies to dengue, Japanese encephalitis \[[@pone.0229314.ref014]\], and WNV \[[@pone.0229314.ref015]\] has been investigated previously but existing studies required the use of host-specific conjugated antibodies. This is of little utility for the investigation of complex zoonoses like RRV where the hosts are myriad or unknown. The "gold standard" of serological tests is the Plaque Reduction Neutralisation Test (PRNT) \[[@pone.0229314.ref016]\]. It does not need prior knowledge of host origin but typically requires large quantities of sera or tissue; substantially larger than a typical mosquito blood meal (estimated to be 3 μl \[[@pone.0229314.ref017], [@pone.0229314.ref018]\]).

We developed a micro-PRNT \[[@pone.0229314.ref019], [@pone.0229314.ref020]\] to suit small sample volumes. In this alternative approach, we exploit the fact that vertebrate antibodies persist within mosquito blood meals for some time after the mosquito has fed on a seropositive host. We demonstrate that a micro-PRNT technique can identify vertebrate RRV antibodies in small volumes of sera and mosquito blood meals. This has utility as part of an integrated xenodiagnostic approach that exploits the capture of single blood-fed mosquitoes to infer mosquito species, host preference and host exposure to disease. This will help prioritise potential transmission pathways for further study.

Materials and methods {#sec006}
=====================

Cells and virus {#sec007}
---------------

Vero cells (WHO vaccine strain) and the RRV strain T-48 \[[@pone.0229314.ref021]\] were obtained from the WHO Collaborating Centre for Arbovirus Reference and Research at the Queensland University of Technology (QUT). At the QIMR Berghofer Medical Research Institute (QIMRB), virus was propagated in Vero cells maintained in 5% CO~2~ at 37°C in RPMI-1640 growth media (Sigma-Aldrich, Missouri, USA), supplemented with sodium bicarbonate (2 g/L), 10% (v/v) heat-inactivated foetal calf serum (Invitrogen, USA) and 1% (v/v) PSG \[(Penicillin (10,000 units)/Streptomycin (10 mg/mL)/ L-glutamine (200 mM)); Sigma-Aldrich, USA\]. Virus stocks were frozen at -80°C.

Koala sera {#sec008}
----------

Forty-two koala sera, obtained from Endeavour Vets, Queensland, Australia (<http://www.endeavourvet.com.au>) were used to validate the micro-PRNT. These samples were collected between 2015 and 2017 and stored at -80°C.

Mosquitoes {#sec009}
----------

We used two model insects to validate the micro-PRNT. An *Ae*. *aegypti* colony that originated from Cairns, Australia, in 2015 and was reared as previously described \[[@pone.0229314.ref022]\]. Adult mosquitoes were provided with 10% sugar solution *ad libitum* and an opportunity to feed on defibrinated sheep blood once per week. An *Ae*. *notoscriptus* colony was established from eggs collected in Brisbane, Australia during 2015 and maintained as above.

Development of the microPRNT {#sec010}
----------------------------

All koala serum samples were tested for neutralising RRV antibodies using a conventional PRNT approach. Equal volumes of sera (200 μl), diluted 1:20 in serum-free RPMI-1640, were mixed with an equal volume of 50 plaque forming units of RRV (1:800 stock RRV in RPMI-1640) per well of a 12-well tissue culture plate (Nunclon, Thermo Scientific, Australia). The virus-sera mixtures were incubated at 37°C for 45 min and added to infect Vero cell monolayers and incubated for a further two hours to enable non-neutralised virus to adsorb to cells. Following incubation, the virus-sera mixture was removed and 2 mL of 0.75% w/v carboxymethyl cellulose (CMC, Sigma-Aldrich) in RPMI 1640 was added. Plates were incubated at 37°C in 5% v/v CO~2~ for an additional 40 hr. The CMC/RPMI medium was then removed, and the cell monolayers were fixed and stained with 0.05% w/v crystal violet (Sigma-Aldrich) in formaldehyde (1% v/v) and methanol (1% v/v). The cell monolayers were then rinsed in tap water, and the plates inverted on a paper towel until dry. Plaques (clear zones in a purple cell monolayer) were counted. Reductions of total virus plaque numbers per well of ≥50% were considered to denote seropositive status \[[@pone.0229314.ref013]\].

All koala samples were also tested by a micro-PRNT technique using just three μl of koala sera; the approximate volume of a mosquito blood meal \[[@pone.0229314.ref017]\]. Sera were diluted 1:20 in serum-free RPMI-1640. Equal volumes of diluted sera (50 μl) were then mixed with equal volumes of 30 pfu RRV per well (1:160 stock RRV in RPMI-1640) and added to duplicate wells (50 ul per well) of 96--well tissue culture plates (Nunclon, Thermo Scientific, Australia) containing a Vero cell monolayer. A virus density of 30 pfu per well in 96-well plates allowed sufficient visual discrimination of plaques \[[@pone.0229314.ref023]\]. A volume of 200μl CMC/RPMI was added to each well following infection of the cell monolayer. Plates were scanned at 600 dpi resolution (HP Scanjet, Palo Alto, USA) and images were magnified before counting plaques manually.

The agreement between the percent plaque neutralisation from both the conventional and micro-PRNT was determined by paired sample t-test (n = 42, each serum sample tested once with each PRNT protocol).

Preparation of blood fed mosquitoes {#sec011}
-----------------------------------

Blood cells from defibrinated sheep blood (Serum Australis, Manilla, NSW, Australia) were pelleted, washed three times in PBS and then reconstituted in either RRV seropositive or RRV seronegative human sera at a physiological proportion of 1: 0.82 blood cell: plasma. The blood was previously confirmed to be seronegative for RRV by conventional PRNT. Female *Ae*. *aegypti* mosquitoes (aged 3--5 days) were starved for 5 hr to increase their avidity and then offered seropositive or seronegative blood for 30 min via a membrane feeding apparatus \[[@pone.0229314.ref024]\]. Fully engorged and unfed mosquitoes from each treatment group were maintained separately at 27±1°C and 80% relative humidity and provided with 10% sucrose solution *ad libitum*. At 6, 12, 24, 36, 48, 60 and 72 hr post exposure to the infected and uninfected blood meals, fed and unfed mosquitoes (the latter used as controls) were harvested and stored at -80 °C.

In a separate experiment, to validate the micro-PRNT on blood meals from mosquitoes that had fed directly on vertebrate hosts, *Ae*. *notoscriptus* were fed on the exposed arms of RRV seropositive and seronegative human volunteers (previously confirmed by conventional PRNT) for a period of 15 min. Fully engorged mosquitoes were selected for analysis, maintained and harvested as above. Remnant blood could be observed in mosquito abdomens until 60 hours ([Fig 1](#pone.0229314.g001){ref-type="fig"}).

![*Aedes notoscriptus* at different stages of blood meal digestion.\
Immediately after feeding (0 hr), mosquitoes were fully engorged. After 72 hr, the blood meal could no longer be seen.](pone.0229314.g001){#pone.0229314.g001}

Informed, written consent was given for collection of volunteer blood samples and the direct feeding of mosquitoes on sero-negative and sero-positive humans (QIMR Berghofer Human Research Ethics approval P2273).

Validation of the micro-PRNT using blood-fed mosquitoes {#sec012}
-------------------------------------------------------

The blood meal volume obtained from a single field-collected, blood-fed mosquito is sufficient for the micro-PRNT assay, but in order to ascertain the assay's robustness against a range of host antibody titres and post-feeding times, and facilitate the dilutions that these experiments required, we used larger volumes of mosquito-derived blood in our validations. These were obtained by pooling three blood meals from engorged mosquitoes that had fed on the same antibody-positive source. One pool was used for each post-feeding time point tested. Abdominal contents were diluted by 1:20, 1:40, 1:80 and 1:160 using serum-free RPMI 1640 supplemented with 1% PSG and 0.4% amphotericin B (Sigma-Aldrich, USA). The final reported blood volume was calculated based on dilution of a 3 μl blood meal \[[@pone.0229314.ref017]\] \[[@pone.0229314.ref018]\]. A range of controls were also processed to assess the impacts of sero-negative mosquito homogenates on the inhibition of plaque forming units. This entailed a comparison of 1) RRV alone 2) RRV plus unfed mosquito abdomens, and 3) RRV plus the abdomens of mosquitoes that contained sheep blood supplemented with seronegative human sera. In every case, the RRV pfu was kept constant.

To validate the ability of the micro-PRNT to detect vertebrate anti-RRV antibodies from single, blood fed mosquitoes, we tested *Aedes notoscriptus* that had been fed on human seropositive or seronegative volunteers. Blood-fed mosquitoes were harvested at various times post-feeding and processed as above (abdominal contents expelled into serum-free RPMI 1640 and adjusted to obtain a 20-fold dilution). Unfed mosquitoes were included as a control. Each 96-well plate was scanned and plaques were counted manually as described above.

Identification of host DNA {#sec013}
--------------------------

Sixteen blood meal samples harvested after feeding on RRV seropositive sheep blood or human blood (n = 8 for each) were used to demonstrate that host identification could be performed in parallel with the micro-PRNT on the same blood samples. PCR amplification of *Cytochrome b* was performed as previously described \[[@pone.0229314.ref025]\].

Results {#sec014}
=======

Comparison of micro-PRNT and PRNT {#sec015}
---------------------------------

RRV plaques on cell layers stained 40 hr post-incubation were clearly distinguishable and easily counted when plates were scanned and images enlarged. There was a significant correlation (R^2^ = 0.65; P\<0.0001) between percent neutralisation of RRV pfu noted in koala samples characterized by micro-PRNT or PRNT techniques ([Fig 2](#pone.0229314.g002){ref-type="fig"}). In comparison to the standard PRNT, the sensitivity and specificity of the micro-PRNT was 88.2% and 96% respectively. Those differences in percent neutralisation determined between methods were not significant (*p* \> 0.05; paired samples t-test).

![Plaque neutralisation demonstrated by standard PRNT or micro-PRNT using koala serum samples.\
Correlation of percent reduction in plaque forming units as measured by standard PRNT (x-axis) and micro-PRNT (y-axis) techniques.](pone.0229314.g002){#pone.0229314.g002}

Impacts of mosquito homogenates on the number of plaque forming units {#sec016}
---------------------------------------------------------------------

Vero cells were inoculated with RRV alone, RRV mixed with homogenates of unfed mosquito abdomens and homogenates of abdomens containing RRV seronegative sheep blood. There was a small (10%) but significant decrease in RRV pfu when Vero cells were inoculated with RRV mixed with the latter two samples ([Fig 3](#pone.0229314.g003){ref-type="fig"}).

![The effect of mosquito homogenates on plaque formation.\
Homogenates of mosquito abdomens reduce the number of plaque forming units by approximately 10%, when compared with Vero cells inoculated with RRV alone (\*p\<0.05, calculated by one-way ANOVA test).](pone.0229314.g003){#pone.0229314.g003}

Validation of the assay using mosquito blood meals {#sec017}
--------------------------------------------------

Mosquito blood meals obtained from mosquitoes membrane-fed on sheep blood mixed with anti-RRV human antibodies neutralised RRV by ≥50% until 60 hr post blood feeding ([Fig 4](#pone.0229314.g004){ref-type="fig"}). In contrast, there was no neutralisation of blood meals obtained from mosquitoes fed with sheep blood supplemented with RRV seronegative human serum. These assays demonstrated that the micro-PRNT is robust across a range of dilutions that are likely to represent varying antibody levels in the host.

![Percent neutralisation of RRV by vertebrate antibodies in mosquito blood meals harvested at different time points post blood-feeding.\
Blood meals obtained from RRV positive sera and harvested at different times post-feeding were diluted at four different concentrations and tested in duplicate. Antibodies continued to neutralise ≥ 50% of plaques at all dilutions, until 60 hr post feeding.](pone.0229314.g004){#pone.0229314.g004}

Guided by the results detailed in [Fig 4](#pone.0229314.g004){ref-type="fig"}, we used the 1:20 dilution for all subsequent micro-PRNTs on single blood meals from live hosts. Single *Ae*. *notoscriptus* blood meals obtained by feeding mosquitoes on a seropositive human volunteer were harvested at different time points. These blood meal preparations neutralised RRV pfu by ≥50% until 48 hr post feeding. ([Fig 5A](#pone.0229314.g005){ref-type="fig"}). The limited neutralising effects of sero-negative blood meals ([Fig 5B](#pone.0229314.g005){ref-type="fig"}) and un-fed mosquito abdomens are included for comparison ([Fig 5C](#pone.0229314.g005){ref-type="fig"}).

![Impact of post-feeding times on neutralisation of RRV.\
Blood meals from an RRV seropositive human volunteer (A), blood meals from an RRV seronegative human volunteer (B) and unfed mosquito abdomens as a control (C). Antibody positive blood meals continued to neutralise ≥ 50% of plaques until 48 hours post-feeding.](pone.0229314.g005){#pone.0229314.g005}

Host identification of blood meal samples {#sec018}
-----------------------------------------

Sequencing of *cytochrome b* amplicon-DNA from all 16 blood meal samples correctly identified (\>95% nucleotide identity to *cytochrome b* sequences) the origin of the blood meal source (i.e. sheep from those experiments that had used membrane feeds, and human where mosquitoes had fed on volunteers).

Discussion {#sec019}
==========

Mosquito blood meals are a potentially useful resource for assessing antibody seroprevalence in vertebrates and inferring the RRV transmission pathways between vectors, disease reservoirs and humans. This study demonstrates that a micro-PRNT using 96-well plates has considerable utility for characterizing the antibody content of small blood volumes and is equivalent in sensitivity and specificity to the "gold standard" conventional PRNT method. In conjunction with the species identification of the blood-fed mosquito, and the use of existing molecular tools to identify the host origin of the blood meal, this new diagnostic has the capacity to increase our understanding of the key pathways for the transmission of complex zoonotic arboviruses.

The accuracy of the micro-PRNT for testing RRV antibodies in this study compared favourably with a conventional PRNT method when applied to our koala samples. Similarly, confluent results were reported for a micro-PRNT tested against yellow fever virus in artificially spiked serum samples \[[@pone.0229314.ref019]\]. Although alternatives to the PRNT such as a VecTest-inhibition assay and a biotin microsphere immunoassay have been used to identify pathogen-specific antibodies in mosquito blood meals \[[@pone.0229314.ref015]\]; both require host-specific antibodies and the latter demands considerable laboratory resources. Our micro-PRNT demonstrates sufficient sensitivity, specificity and utility for the determination of RRV antibodies in blood-fed mosquitoes that have fed on any vertebrate.

Our micro-PRNT could detect ≥50% RRV neutralisation by mosquito blood meals up to 36--48 hr post blood-feeding. Although this is the first study to have identified RRV antibodies in mosquito blood meals, more general studies have shown that antibodies can survive in those environments. Hatfield (1988) identified Bovine Serum Albumin (BSA) specific antibodies using antibody-captured ELISA from the hemolymph of *Ae*. *aegypti* up to 48 hr after feeding \[[@pone.0229314.ref026]\]. Irby and Apperson (1989) used an immunoblot technique to demonstrate that serum proteins from rodents and humans persisted in *Ae*. *aegypti* blood meals for 36 to 48 hr post-feeding \[[@pone.0229314.ref027]\]. Anti-BSA antibodies were detected 9 days after blood feeding in *Anopheles stephensi* \[[@pone.0229314.ref028]\] and human specific IgM and IgG were present in the blood meals of *Ae*. *albopictus* for 7 days \[[@pone.0229314.ref029]\]. These extended periods are surprising given that one would expect blood meals and their proteins to have been fully digested by then but the persistence of antibodies in mosquito blood meals will differ with species, ambient temperature, body size, initial concentration of antibodies, blood meal volume and the length of the gonotrophic cycle. In our study, the period of detectability (48--60 hr) corresponded to the period that blood was externally visible in the abdomen ([Fig 1](#pone.0229314.g001){ref-type="fig"}).

The small volumes of homogenate left from a single mosquito after execution of the micro-PRNT allows for a parallel PCR amplification for identification of the blood meal source (the host). The literature commonly reports that the origin of host blood meals can be identified from as a little as 0.02 μl of blood \[[@pone.0229314.ref030]\]. In our proof of principle, 10 μl aliquots of 1:20 diluted homogenate recovered from the micro-PRNT 60 hr post blood-feeding were successfully amplified and sequenced to identify our experimental donors: sheep and humans.

Given the challenges involved in obtaining, trapping and screening wild animals for serum sampling and sero-prevalence studies \[[@pone.0229314.ref013]\], the collection of blood fed mosquitoes is a useful means of sampling, with mosquitoes acting as an indirect sampling tool or "flying syringe" for sampling inaccessible or ethically challenging hosts. In terms of pathway incrimination, a single mosquito will yield information on vectors, host preference and the disease exposure of that host \[[@pone.0229314.ref011]\]. That information, especially when combined with risk modelling \[[@pone.0229314.ref031]\] can be used to identify those transmission pathways of greatest importance within the host community. Various studies have observed the potential for insect blood meals to detect pathogen specific antibodies \[[@pone.0229314.ref026], [@pone.0229314.ref032]--[@pone.0229314.ref034]\], but none have developed high throughput methods suitable for application to transmission ecologies involving unknown reservoirs.

Human health can be affected by infectious diseases of wildlife living close to human habitation. The risks are increasingly common in Australia and elsewhere because of increasing encroachment of the human population on diverse mosquito habitats and the adaptation of pathogen reservoir species to urbanized environments \[[@pone.0229314.ref035], [@pone.0229314.ref036]\]. Dengue, Hantavirus, Lyme disease, Zika, avian influenza, and rabies are examples of globally endemic zoonoses that have emerged from human encroachment into rural or sylvatic habitats \[[@pone.0229314.ref037], [@pone.0229314.ref038]\]. Similarly, RRV is a major public health risk in Australia, maintained in a diverse range of hosts and vectors and undergoing an expansion in range to the Pacific Islands \[[@pone.0229314.ref039]\].

Infectious diseases are also a concern for wildlife conservation, particularly those already threatened by habitat loss and exploitation. Surveillance of wild animals for infection or disease commonly involves trapping or killing animals for direct sampling of blood and tissues. This can be difficult, expensive, dangerous and sometime unethical. The technique demonstrated here is not only applicable to RRV reservoir identification but also to other arboviruses and infectious agents which have complex transmission cycles and a range of vertebrate hosts.

There was a ≈10% inhibition of virus pfu by mosquito tissue homogenates ([Fig 3](#pone.0229314.g003){ref-type="fig"}). However, this inhibition was minimal compared to the threshold used to determine positive neutralisation (\>50% reduction). One possible explanation of this observation is that some component of abdominal tissue may have an inhibitory effect on virus replication.

As for all serum or tissue collection techniques, reliance on blood-fed mosquitoes as a sampling tool will be subject to sampling bias. Mosquitoes may be differentially attracted to diseased hosts \[[@pone.0229314.ref040]\] or to species that are uncharacteristically abundant at any single point in time. Different mosquito trapping techniques have differential vector specific targets, so using one particular trap type might miss key vector species. In terms of serology, there may be considerable cross reaction between some virus antibodies \[[@pone.0229314.ref012]\]. In this case RRV is likely to cross-react with the closely related alphavirus, Barmah Forest virus, whose epidemiology in Queensland remains significant \[[@pone.0229314.ref002]\]. Finally, those reservoirs inferred by blood meal analysis may not be the key amplifying host, and the mosquitoes incriminated may not be the key vector. For example, dengue antibodies are commonly found in *Culex* spp. mosquitoes during epidemics, but those mosquitoes do not transmit the disease. Nonetheless their blood meals may still identify the host and its sero-prevalence rate \[[@pone.0229314.ref014]\]. For all of these reasons, the various components of the pathways implicated by the micro-PRNT technique and attendant host identifications must be interpreted and prioritised in the light of all the available knowledge on the ecology of the disease.

Conclusions {#sec020}
===========

The value of the micro-PRNT lies in its ability to detect anti-virus antibodies from mosquito blood meals obtained from any vertebrate host. When coupled with molecular identification of the host by DNA amplification and sequencing, valuable information on vector-host relationships, wildlife sero-prevalence rates and zoonotic transmission cycles can be inferred \[[@pone.0229314.ref014]\]. This novel xenodiagnostic offers an alternative "flying syringe" approach for serum sampling and for monitoring sero-prevalence in animals. The use of this assay to characterise the blood meals of mosquitoes collected from the field in Brisbane is now underway.
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Manuscript ID PONE-D-20-02979 Response to Reviewers

Title: A micro-PRNT for the detection of Ross River virus antibodies in mosquito blood meals: a useful tool for inferring transmission pathways.

Comments to the Editor

We have amended the ethics statements according to your instructions. Written consent was required by volunteers. That information is now included in the last paragraph of the section "Preparation of blood fed mosquitoes".

We have made a number of changes to the text, additional to the requests may by the reviewers. These are visible in the track changed R1 manuscript. There have been no changes in context, methodology or interpretation but we have altered sections of text for clarity or to correct grammar. The major changes are detailed below:

1\. Introduction: We have moved two paragraphs form the end of the introduction to further up the page.

2\. Preparation of blood fed mosquitoes: First and last paragraphs revised for methodological clarity and to include requested information on ethics.

3\. Validation of the micro PRNT: We have clarified some of information on blood meal volumes.

4\. The text in the discussion has been improved for flow and clarity, but the interpretation of results has not changed.

Response to Reviewers

Reviewer \#1

Comment 1: Interesting technical paper with only minor edits.

Line 70 use of word \"encourage\" needs to be re-examined

Line 91 West Nile viruses

Lines 233 and 241 missing period.

Line 302 sometimes

Response: We thank the reviewer for their positive assessment of the study and for identifying these minor edits. These have been corrected in the updated manuscript.

Comment 2: Overall - I am not sure how useful some of the figures are. Figure 1 needs T=0 or state it was fully engorged - even with this I am not sure it really adds anything.

Figure 4 B and C - so small hard to see better to summarize data and leave the plates out?

Response: We feel that Fig 1 is a useful visual representation of the amount of blood present at various times post feeding. We have updated Fig 1 to include 0 (fully engorged) and 6h post feeding.

For Fig 4, we agree with the reviewer. We have removed the photos of the micro-titre plates, leaving only the line graph to demonstrate the relationship between antibody concentration and plaque inhibition over time.

Reviewer \#2

Comment 1: The work proposes the use of micro PRNT from blood present in mosquito abdomens, useful tool for viral ecology projects, standardized in that study for Ross River virus. Very important and well-designed work.

Line 96 -- What is \"ca\"? Appears on line 305 again.

Line 107 -- The reagent \"L-glutamine (200 mM)\" is repeated in the formulation. I believe it must be an antimicrobial, perhaps Gentamicin.

Lines 171 -- 172 "The volume of RPMI 1640 was adjusted to obtain a 20-fold dilution of the blood." What level of volume control is there in this process? Is the blood volume measured? That part was not clear.

Lines 180 -- 181 "Aedes notoscriptus that had been fed on human seropositive or seronegative volunteers" Mention the quality control that is done on these mosquitoes, as they were used to feed on human volunteers.

The legends of figures 1, 2 and 3 are incomplete. In all of them the information needs to be complemented.

Response: We thank the reviewer for their positive assessment of the study.

"ca" (Circa) has been replaced with "approximately".

We have removed reference to L-glutamine which is an amino acid and a common additive to cell culture media.

We used fully engorged mosquitoes, published estimates of mean blood volumes (e.g Konishi 1989, Jeffery 1956) and applied dilution factors to those published estimates.

All mosquitoes were from established, uninfected colonies. The sero-status of human volunteers was confirmed by standard PRNT. Each blood-feed lasted until engorgement or termination (30 minutes). Only mosquitoes that were fully engorged were selected for further analysis. Three engorged mosquitoes per time point were chosen for analysis.

We have attempted to make this process clearer in the methods section under 'Preparation of blood fed mosquitoes'.

The legends for figures 1, 2 and 3 have been expanded.

Comment 2: There is a lack of discussion topic of the complexity of using the tool in fieldwork regarding the possible species involved as hosts. According to the protocol described here, the volume would be enough to screen how many species? Does the protocol allow a focused or broad-spectrum host approach? The proof of concept was made with blood obtained from human and sheep, but how would be the use of the protocol in other works, considering that this is the final objective of the publication.

Response: We believe that we have already acknowledged the complexity in interpretation in our discussion, having referred to sampling bias, cross-reactivity, inability to identify all potential vertebrate hosts and the fact that the presence of antibody in a mosquito blood meal does not necessarily define that mosquito as a key vector.

Our proof of principle shows that the same mosquito blood meals can be used to identify the host origin of the blood meal and whether that host had been exposed to a target virus (in this case the arbovirus RRV). The technique provides clues to potential transmission pathways, but is not definitive.

We agree with the reviewer that a broad spectrum of hosts might be represented in mosquito blood meals. Although we used human and sheep blood for demonstration purposes, sequencing data from a single, tiny aliquot of serum can be matched to myriad vertebrate sequences available online.
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Click here for additional data file.
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Dear Dr. Gyawali,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Luciano Andrade Moreira, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: I Don\'t Know

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Thank you for the edits, this reads much better now and the figures presented are more appropriate. This is an interesting technique that can potentially be modified and used for other arboviruses.

There are 2 missing a periods in lines 239 and 246 at the end of the paragraphs.

Reviewer \#2: (No Response)

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No
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Dear Dr. Gyawali:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.
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PLOS ONE Editorial Office Staff
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Dr. Luciano Andrade Moreira

Academic Editor
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